JP2000506736A - 医薬品質のプラスミドdnaの精製 - Google Patents
医薬品質のプラスミドdnaの精製Info
- Publication number
- JP2000506736A JP2000506736A JP9533199A JP53319997A JP2000506736A JP 2000506736 A JP2000506736 A JP 2000506736A JP 9533199 A JP9533199 A JP 9533199A JP 53319997 A JP53319997 A JP 53319997A JP 2000506736 A JP2000506736 A JP 2000506736A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- plasmid
- buffer
- column
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.少なくとも1つのセラミックヒドロキシアパタイトカラムクロマトグラフィ ー段階を含むことを特徴とする医薬純度の二重鎖DNAの精製方法。 2.2つのクロマトグラフィー段階を含み、一方の段階がヒドロキシアパタイト カラムにおいて行われることを特徴とする二重鎖DNAの精製方法。 3.1つのヒドロキシアパタイトカラムクロマトグラフィー段階と1つのアフィ ニティークロマトグラフィー段階またはイオン交換クロマトグラフィー段階とを 含むことを特徴とする請求項2に記載の方法。 4.1つのヒドロキシアパタイトカラムクロマトグラフィー段階と、DNA配列 と固定化オリゴヌクレオチドとの特異的ハイブリダイゼーションによって三重螺 旋の形成を伴う1つのアフィニティークロマトグラフィー段階とを含むことを特 徴とする請求項3に記載の方法。 5.1つのヒドロキシアパタイトカラムクロマトグラフィー段階と1つのアニオ ン交換クロマトグラフィー段階とを含むこと を特徴とする請求項3に記載の方法。 6.更に、透析濾過段階を含むことを特徴とする請求項1から5のいずれか一項 に記載の方法。 7.細胞の化学的溶解段階と、 透析濾過段階と、 セラミックヒドロキシアパタイトカラムクロマトグラフィー段階と、 DNA配列と固定化オリゴヌクレオチドとの特異的ハイブリダイゼーションによ って三重螺旋の形成を伴うアフィニティークロマトグラフィー段階と、 を含むことを特徴とする二重鎖DNAの精製方法。 8.二重鎖DNAが更に1つまたは複数の有益な配列を含むことを特徴とする請 求項1から7のいずれか一項に記載の方法。 9.二重鎖DNAがプラスミドDNAであることを特徴とする請求項1から8の いずれか一項に記載の方法。 10.染色体DNAの含量が0.01%以下であることを特徴とする組換えプラ スミドDNA調製物。 11.内毒素の含量が50EU/mg以下であることを特徴とする請求項10に 記載の精製された組換えプラスミドDNA調 製物。 12.内毒素の含量が10EU/mg以下であることを特徴とする請求項11に 記載の精製された組換えプラスミドDNA調製物。 13.請求項1から9のいずれか一項に記載の方法によって得られたDNAを含 む医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9603519A FR2746412B1 (fr) | 1996-03-21 | 1996-03-21 | Purification d'adn plasmidique de qualite pharmaceutique |
FR96/03519 | 1996-03-21 | ||
PCT/FR1997/000472 WO1997035002A1 (fr) | 1996-03-21 | 1997-03-17 | Purification d'adn plasmidique de qualite pharmaceutique |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000506736A true JP2000506736A (ja) | 2000-06-06 |
Family
ID=9490391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9533199A Pending JP2000506736A (ja) | 1996-03-21 | 1997-03-17 | 医薬品質のプラスミドdnaの精製 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6730781B1 (ja) |
EP (1) | EP0902835A1 (ja) |
JP (1) | JP2000506736A (ja) |
KR (1) | KR100502116B1 (ja) |
AU (1) | AU730755B2 (ja) |
BR (1) | BR9708227A (ja) |
CA (1) | CA2249465A1 (ja) |
CZ (1) | CZ295587B6 (ja) |
FR (1) | FR2746412B1 (ja) |
HU (1) | HU225426B1 (ja) |
IL (1) | IL126268A0 (ja) |
NO (1) | NO984342L (ja) |
SK (1) | SK129198A3 (ja) |
WO (1) | WO1997035002A1 (ja) |
ZA (1) | ZA972462B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505613A (ja) * | 2003-09-17 | 2007-03-15 | センテリオン | 医薬品グレードのプラスミドdnaの作成方法 |
JP2007532123A (ja) * | 2004-04-19 | 2007-11-15 | センテリオン | 医薬品グレードのプラスミドdnaの作成方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026468B2 (en) | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
US7807822B2 (en) | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
US6214586B1 (en) * | 1997-12-08 | 2001-04-10 | Genzyme Corporation | Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA |
ES2298239T3 (es) * | 2000-05-26 | 2008-05-16 | Centelion | Purificacion de una formacion de triple helice con oligonucleotido inmovilizado. |
FR2822476B1 (fr) * | 2001-03-23 | 2004-04-02 | Aventis Pharma Sa | Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice |
KR20030088464A (ko) * | 2001-03-23 | 2003-11-19 | 진셀 소시에테 아노님 | 2본쇄 dna 표적 서열을 3중 나선 상호작용에 의해 정제및 검출하는 방법 |
EP1554398A4 (en) | 2002-09-13 | 2005-12-14 | Valentis Inc | DEVICE AND METHOD FOR THE CLEANING OF NUCLEAR SULFUR IN THE PREPARATIVE SCALE |
CA2567324C (en) | 2003-05-30 | 2012-01-03 | Advisys, Inc. | Devices and methods for biomaterial production |
PL1737945T3 (pl) * | 2004-04-19 | 2011-07-29 | Aventis Pharma Sa | Sposób oczyszczania plazmidowego DNA |
WO2006026125A2 (en) | 2004-08-16 | 2006-03-09 | Nature Technology Corp. | Improved strains of e. coli for plasmid dna production |
EP1817423B1 (en) | 2004-11-30 | 2015-01-07 | Merial Ltd. | Mixing devices for chemical lysis of cells |
US20120258502A1 (en) * | 2011-04-08 | 2012-10-11 | Vinod Pandiripally | Method of producing recombinant plasmid dna using substantially solid growth medium |
US20120283503A1 (en) * | 2011-04-29 | 2012-11-08 | The Johns Hopkins University | Nanoparticle loaded stem cells and their use in mri guided hyperthermia |
CN116790578B (zh) * | 2023-08-22 | 2023-12-12 | 赛奥斯博生物科技(北京)有限公司 | 一种基于碱裂解法快速纯化质粒的生产工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0313090B1 (en) * | 1987-10-22 | 1994-03-02 | Asahi Kogaku Kogyo Kabushiki Kaisha | Porous ceramic material |
JPH01135792A (ja) * | 1987-11-20 | 1989-05-29 | Mitsui Toatsu Chem Inc | 核酸の分離・精製方法 |
CA2006008C (en) * | 1988-12-20 | 2000-02-15 | Donald J. Kessler | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
AU6125294A (en) * | 1993-01-13 | 1994-08-15 | Genetics Institute Inc. | Process for producing m-csf 223 |
US5503816A (en) * | 1993-09-27 | 1996-04-02 | Becton Dickinson And Company | Silicate compounds for DNA purification |
EP0743949B1 (de) * | 1994-02-07 | 1999-12-15 | QIAGEN GmbH | Verfahren zur herstellung endotoxinfreier oder an endotoxin abgereicherter nucleinsäuren und/oder oligonucleotide für die gentherapie |
US5576196A (en) * | 1995-01-13 | 1996-11-19 | Vical Incorporated | Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth |
US6750333B1 (en) | 1996-02-06 | 2004-06-15 | Roche Diagnostics Gmbh | Process for preparing purified nucleic acid and the use thereof |
-
1996
- 1996-03-21 FR FR9603519A patent/FR2746412B1/fr not_active Expired - Fee Related
-
1997
- 1997-03-17 IL IL12626897A patent/IL126268A0/xx unknown
- 1997-03-17 JP JP9533199A patent/JP2000506736A/ja active Pending
- 1997-03-17 BR BR9708227A patent/BR9708227A/pt not_active Application Discontinuation
- 1997-03-17 CZ CZ19982984A patent/CZ295587B6/cs not_active IP Right Cessation
- 1997-03-17 WO PCT/FR1997/000472 patent/WO1997035002A1/fr not_active Application Discontinuation
- 1997-03-17 EP EP97914411A patent/EP0902835A1/fr not_active Ceased
- 1997-03-17 SK SK1291-98A patent/SK129198A3/sk unknown
- 1997-03-17 HU HU9902152A patent/HU225426B1/hu not_active IP Right Cessation
- 1997-03-17 CA CA002249465A patent/CA2249465A1/fr not_active Abandoned
- 1997-03-17 AU AU21661/97A patent/AU730755B2/en not_active Ceased
- 1997-03-17 KR KR10-1998-0707410A patent/KR100502116B1/ko not_active IP Right Cessation
- 1997-03-20 ZA ZA9702462A patent/ZA972462B/xx unknown
-
1998
- 1998-09-15 US US09/153,838 patent/US6730781B1/en not_active Expired - Fee Related
- 1998-09-18 NO NO984342A patent/NO984342L/no not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505613A (ja) * | 2003-09-17 | 2007-03-15 | センテリオン | 医薬品グレードのプラスミドdnaの作成方法 |
JP2007532123A (ja) * | 2004-04-19 | 2007-11-15 | センテリオン | 医薬品グレードのプラスミドdnaの作成方法 |
Also Published As
Publication number | Publication date |
---|---|
SK129198A3 (en) | 1999-03-12 |
KR20000064693A (ko) | 2000-11-06 |
NO984342D0 (no) | 1998-09-18 |
HUP9902152A2 (hu) | 1999-11-29 |
FR2746412B1 (fr) | 1998-06-12 |
HU225426B1 (en) | 2006-11-28 |
US6730781B1 (en) | 2004-05-04 |
CZ295587B6 (cs) | 2005-08-17 |
AU2166197A (en) | 1997-10-10 |
BR9708227A (pt) | 1999-07-27 |
KR100502116B1 (ko) | 2005-12-20 |
FR2746412A1 (fr) | 1997-09-26 |
IL126268A0 (en) | 1999-05-09 |
NO984342L (no) | 1998-09-18 |
AU730755B2 (en) | 2001-03-15 |
EP0902835A1 (fr) | 1999-03-24 |
CZ298498A3 (cs) | 1999-01-13 |
ZA972462B (en) | 1997-09-29 |
CA2249465A1 (fr) | 1997-09-25 |
HUP9902152A3 (en) | 2001-04-28 |
WO1997035002A1 (fr) | 1997-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000506736A (ja) | 医薬品質のプラスミドdnaの精製 | |
EP1664277B1 (en) | Method of preparation of pharmaceutically grade plasmid dna | |
JP2009045070A (ja) | 固定化させたオリゴヌクレオチドと三重らせんを形成させることによるdna精製 | |
MXPA06011568A (es) | Metodo para purificar adn plasmidico. | |
US8399636B2 (en) | Purification of a triple helix formation with an immobilized obligonucleotide | |
JP4444564B2 (ja) | 三重螺旋相互作用によるターゲット二本鎖dna配列の精製及び検出方法 | |
AU2007202804B8 (en) | Purification of a triple helix formation with an immobilized oligonucleotide | |
EP1737945B1 (en) | Method for purifying plasmid dna | |
US7052838B2 (en) | Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction | |
AU2001263459A1 (en) | Purification of a triple heli formation with an immobilized oligonucleotide | |
MXPA98007323A (en) | Purification of plasmid dna of pharmaceutical quality | |
PL206844B1 (pl) | Sposoby oczyszczania dwuniciowego DNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040223 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050304 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20050304 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060808 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061107 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061225 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070207 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070327 |